Events - Spark Newswire

1 minute read

NVIDIA Announces OVX Computing Systems Powered By Ada Lovelace GPU

Today, 9:13 AM

NVIDIA today announced the second generation of NVIDIA OVX™, powered by the NVIDIA Ada Lovelace GPU architecture and enhanced networking technology, to deliver groundbreaking real-time graphics, AI and digital

NVDA

1 minute read

Events
News

NVIDIA Launches Omniverse Cloud Services For Building and Operating Industrial Metaverse Applications

By Benzinga Newsdesk

Today, 9:13 AM

GTC -- NVIDIA today announced its first software- and infrastructure-as-a-service offering — NVIDIA Omniverse™ Cloud — a comprehensive suite of cloud services for artists, developers and

NVDA

1 minute read

Events
News

NVIDIA Launches GeForce RTX 40 Series

By Benzinga Newsdesk

Today, 9:13 AM

NVIDIA today unveiled the GeForce RTX® 40 Series of GPUs, designed to deliver revolutionary performance for gamers and creators, led by its new flagship, the RTX 4090 GPU, with up to 4x the

NVDA

1 minute read

The Man Who Took Over AC Milan Owns These 2 Dividend Stocks

By Robert Kuczmarski

Today, 9:13 AM

Activist investor Paul Singer is the founder, president and co-CEO of Elliott Management, which was founded in 1977 with $1.3 million and is now controlling some $45 billion in assets under management.

HWM

2 minute read

Falling Home Sales Send Shock Waves Through Home Retailers And Flippers: How Bad Could It Get?

By Robert Kuczmarski

Today, 9:13 AM

As mortgage rates topped 6%, for the first time since the 2008 financial crisis, new home buyers are being squeezed on multiple fronts since elevated home prices, interest rates, and rising inflation are adding to everyone's bottom line.

LESL

3 minute read

Sage Therapeutics And Biogen Present New Analyses At Psych Congress Further Evaluating The Efficacy And Safety Of Zuranolone

By Benzinga Newsdesk

Today, 9:13 AM

Sage Therapeutics, Inc. (NASDAQ:SAGE) and Biogen Inc. (NASDAQ:BIIB) today announced new analyses from across the development program for zuranolone, an investigational, oral, once-daily, 14-day treatment in clinical

BIIB

2 minute read

2 Blue Chip Stocks Tiger Management Favors For Reliability During Turbulent Markets

By Robert Kuczmarski

Today, 9:13 AM

The late Julian Robertson, founder of hedge fund Tiger Management, earned an annual return of 31.7% from its inception in 1980 to its peak in 1998, compared to 12.7% annual returns in the S&P 500.

2 minute read

Why Hedge Funds Are Piling In These 2 High Yielding Stocks

By Robert Kuczmarski

Today, 9:13 AM

As we move further into the second half of the year, many investors will find themselves repositioning to better allocate their investments to mitigate risks. Some investors prefer to take positions in equities that hedge funds are buying, as large institutional ownership can create more demand for shares.

MRK

4 minute read

Events
News

Medtronic Announced Symplicity HTN-3 Trial Data Show Sustained Long-term Blood Pressure Reductions With Medtronic Renal Denervation Procedure

By Charles Gross

Today, 9:13 AM

Medtronic plc (NYSE: MDT) today announced long-term results from the SYMPLICITY HTN-3 clinical trial.

MDT

2 minute read

The Detroit Auto Show Features Ford Vs. GM EV Faceoff: Check Out The Specs On Their Electric Trucks

By Robert Kuczmarski

Today, 9:13 AM

The annual Detroit Auto Show is open to the public from Sept.17 to Sept. 25, with electric vehicles the primary focus as the Big Three automakers began unveiling their all-new electric fleets in 2022.